Burhanuddin Sohail Rangwala

Burhanuddin Sohail Rangwala

Auto-generated profile, based on publicly available information

Burhanuddin Sohail Rangwala

Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2024 in Frontiers in Pediatrics
Verified
Journal Article
Open access
MMMuhammad Saqlain Mustafa
Muhammad Saqlain Mustafa
MSMuhammad Ashir Shafique
Muhammad Ashir Shafique
SZSyeda Dua E Zehra Zaidi
Syeda Dua E Zehra Zaidi
AQAmna Qamber
Amna Qamber
BRBurhanuddin Sohail Rangwala
Burhanuddin Sohail Rangwala
AHAbdul Haseeb
Abdul Haseeb
Background: This study addresses the pervasive issue of heightened preoperative anxiety in healthcare, particularly among pediatric patients. Recognizing the various sources of anxiety, we explored both pharmacological and nonpharmacological interventions. Focusing on distraction techniques, including active and passive forms, our meta-analysis aimed to provide comprehensive insights into their impact on preoperative anxiety in pediatric patients.Methods: Following the PRISMA and Cochrane guidelines, this meta-analysis and systematic review assessed the efficacy of pharmaceutical and distraction interventions in reducing pain and anxiety in pediatric surgery. This study was registered on PROSPERO (CRD42023449979).Results: This meta-analysis, comprising 45 studies, investigated pharmaceutical interventions and distraction tactics in pediatric surgery. Risk of bias assessment revealed undisclosed risks in performance and detection bias. Distraction interventions significantly reduced preoperative anxiety compared to control groups, with notable heterogeneity. Comparison with Midazolam favored distraction techniques. Subgroup analysis highlighted varied efficacies among distraction methods, with a notable reduction in anxiety levels. Sensitivity analysis indicated stable results. However, publication bias was observed, suggesting a potential reporting bias.Conclusion: Our study confirms distraction techniques as safe and effective for reducing pediatric preoperative anxiety, offering a valuable alternative to pharmacological interventions.Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=449979, PROSPERO [CRD42023449979].

9 July 2024 in Future Science OA
Verified
Journal Article
Open access
BRBurhanuddin Sohail Rangwala
Burhanuddin Sohail Rangwala
VZVarisha Zuhair
Varisha Zuhair
MMMuhammad Saqlain Mustafa
Muhammad Saqlain Mustafa
AMAbdullah Mussarat
Abdullah Mussarat
AKAimen Waqar Khan
Aimen Waqar Khan
MSMuhammad Ashir Shafique
Muhammad Ashir Shafique
Aim: Iron deficiency (ID) is associated with heart failure (HF) in a considerable proportion of patients. To improve the quality of life, lower the frequency of hospitalizations, and lower mortality rates of chronic HF patients (HF), this meta-analysis will look into the role of iron supplementation using ferric carboxymaltose (FCM). Methods & results: From inception until 1 October 2023, we conducted a thorough literature search of electronic databases for peer-reviewed publications. Around 5229 HF patients were included, of which 2691 received FCM while 2538 received placebo. Conclusion: FCM reduces HF-related hospitalizations but doesn't improve overall or cardiovascular mortality in those with HF and ID. The overall results support FCM's role in managing iron deficiency in heart failure.

21 August 2023 in Annals of Neurosciences
Verified
Journal Article
Open access
HFHareer Fatima
Hareer Fatima
HRHussain Sohail Rangwala
Hussain Sohail Rangwala
FRFaiza Riaz
Faiza Riaz
BRBurhanuddin Sohail Rangwala
Burhanuddin Sohail Rangwala
MSMohammad Arham Siddiq
Mohammad Arham Siddiq
Background: Alzheimer’s disease (AD) is a widespread neurodegenerative disorder with a significant global impact, affecting approximately 50 million individuals, and projections estimate that up to 152 million people will be affected by 2050. AD is characterized by beta-amyloid plaques and tau tangles in the brain, leading to cognitive decline. Summary: Recent research on AD has made significant strides, including the development of an “amyloid clock” biomarker that tracks AD progression through positron emission tomography (PET) scans. Surf4 and other genes have been discovered to play a role in regulating beta-amyloid toxicity, while inhibiting the enzyme hexokinase-2 has shown positive results in preclinical studies. New brain mapping techniques have identified early brain-based causes of cognitive changes in AD, and biomarkers such as neuronal pentraxin protein Nptx2 and astrocytic 7-subunit of the nicotinic acetylcholine receptors (7nAChRs) show potential for early detection. Other approaches, such as replenishing the enzyme Tip60, selectively degrading the modified protein p-p38 with PRZ-18002, and targeting the protein voltage-dependent anion channel-1 (VDAC1), have shown promise in enhancing cognitive function and preventing pathophysiological alterations linked to AD. Baseline blood samples and other biomarkers such as urine formic acid, p-tau 198, microRNAs, and glial fibrillary acidic protein (GFAP) have also been discovered for early detection and intervention of AD. Additionally, recent FDA approvals for medications such as aducanumab and lecanemab provide options for reducing AD symptoms and improving function, while clinical trials for dementia vaccines show promise for the nasal and beta-amyloid 40 vaccines as well as vaccinations targeting tau. Key Messages: These advancements in AD research, including biomarker discovery and the development of disease-modifying treatments, are crucial steps towards improving the lives of those affected by AD and finding a cure for this debilitating disease.

27 April 2024 in World Neurosurgery
Verified
Journal Article
Closed access
JIJaved Iqbal
Javed Iqbal
MSMuhammad Ashir Shafique
Muhammad Ashir Shafique
MMMuhammad Saqlain Mustafa
Muhammad Saqlain Mustafa
MCMichael M. Covell
Michael M. Covell
AFAfia Fatima
Afia Fatima
CBChristian A. Bowers
Christian A. Bowers

4 March 2024 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
MSMuhammad Ashir Shafique
Muhammad Ashir Shafique
MMMuhammad Saqlain Mustafa
Muhammad Saqlain Mustafa
Brandon Lucke-WoldBrandon Lucke-Wold
Brandon Lucke-Wold
AKAashish Kumar
Aashish Kumar
BRBurhanuddin Sohail Rangwala
Burhanuddin Sohail Rangwala
AHAbdul Haseeb
Abdul Haseeb

25 March 2024 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
HRHussain Sohail Rangwala
Hussain Sohail Rangwala
HFHareer Fatima
Hareer Fatima
MAMirha Ali
Mirha Ali
MMMuhammad Saqlain Mustafa
Muhammad Saqlain Mustafa
MSMuhammad Ashir Shafique
Muhammad Ashir Shafique
SASyed Raza Abbas
Syed Raza Abbas